About This Event
MapLight Therapeutics, Inc. (Nasdaq: MPLT), a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering from debilitating central nervous system disorders, visits the Nasdaq MarketSite in Times Square.
In honor of the occasion, Chris Kroeger, co-Founder and Chief Executive Officer, rings the Closing Bell.